• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Statin use linked with better outcomes in patients starting ADT for prostate cancer


“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.

In this interview, Robert J. Hamilton, MD, MPH, discusses findings from a recent study published in European Urology titled, “The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,” for which he served as a study author. Hamilton is an associate professor of urology at the University of Toronto.

More videos:

Clinical care pathway demonstrates efficacy for patients with overactive bladder

Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI

A primer for urologists on statutes of limitations

Related Videos
Jaleh Fallah, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
A panel of 4 experts on prostate cancer
A panel of experts on prostate cancer
A panel of 4 experts on prostate cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.